These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21368105)

  • 1. mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia.
    Krymskaya VP; Snow J; Cesarone G; Khavin I; Goncharov DA; Lim PN; Veasey SC; Ihida-Stansbury K; Jones PL; Goncharova EA
    FASEB J; 2011 Jun; 25(6):1922-33. PubMed ID: 21368105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
    Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
    Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of formoterol on thrombin- and PDGF-induced proliferation of human pulmonary arterial vascular smooth muscle cells.
    Goncharova EA; Khavin IS; Goncharov DA; Krymskaya VP
    Respir Res; 2012 Nov; 13(1):109. PubMed ID: 23186269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector.
    Liu X; Wang G; You Z; Qian P; Chen H; Dou Y; Wei Z; Chen Y; Mao C; Zhang J
    Biomaterials; 2014 May; 35(14):4401-16. PubMed ID: 24582377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms.
    Song Y; Wu Y; Su X; Zhu Y; Liu L; Pan Y; Zhu B; Yang L; Gao L; Li M
    Pharmacol Res; 2016 May; 107():117-124. PubMed ID: 26993101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension.
    Wang AP; Li XH; Yang YM; Li WQ; Zhang W; Hu CP; Zhang Z; Li YJ
    PLoS One; 2015; 10(6):e0130806. PubMed ID: 26120832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs.
    Li Y; Yang L; Dong L; Yang ZW; Zhang J; Zhang SL; Niu MJ; Xia JW; Gong Y; Zhu N; Zhang XJ; Zhang YY; Wei XM; Zhang YZ; Zhang P; Li SQ
    Acta Pharmacol Sin; 2019 Oct; 40(10):1322-1333. PubMed ID: 31316183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
    Xiao Y; Peng H; Hong C; Chen Z; Deng X; Wang A; Yang F; Yang L; Chen C; Qin X
    Cell Physiol Biochem; 2017; 42(4):1603-1613. PubMed ID: 28738389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.
    Aghamohammadzadeh R; Zhang YY; Stephens TE; Arons E; Zaman P; Polach KJ; Matar M; Yung LM; Yu PB; Bowman FP; Opotowsky AR; Waxman AB; Loscalzo J; Leopold JA; Maron BA
    FASEB J; 2016 Jul; 30(7):2511-27. PubMed ID: 27006450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
    Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.
    Houssaini A; Abid S; Derumeaux G; Wan F; Parpaleix A; Rideau D; Marcos E; Kebe K; Czibik G; Sawaki D; Treins C; Dubois-Randé JL; Li Z; Amsellem V; Lipskaia L; Pende M; Adnot S
    Am J Respir Cell Mol Biol; 2016 Sep; 55(3):352-67. PubMed ID: 26991739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR-Notch3 signaling mediates pulmonary hypertension in hypoxia-exposed neonatal rats independent of changes in autophagy.
    Ivanovska J; Shah S; Wong MJ; Kantores C; Jain A; Post M; Yeganeh B; Jankov RP
    Pediatr Pulmonol; 2017 Nov; 52(11):1443-1454. PubMed ID: 28759157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.
    Houssaini A; Abid S; Mouraret N; Wan F; Rideau D; Saker M; Marcos E; Tissot CM; Dubois-Randé JL; Amsellem V; Adnot S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):568-77. PubMed ID: 23470622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y; Fanburg BL
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs.
    Tan P; Wang YJ; Li S; Wang Y; He JY; Chen YY; Deng HQ; Huang W; Zhan JK; Liu YS
    Mol Cell Biochem; 2016 Nov; 422(1-2):1-10. PubMed ID: 27619662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
    Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
    Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension.
    Hu S; Zhao Y; Qiu C; Li Y
    Bioengineered; 2022 Feb; 13(2):3516-3526. PubMed ID: 35044284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K/Akt/mTOR signal and the inhibition of autophagy under hypoxia.
    Zhang H; Gong Y; Wang Z; Jiang L; Chen R; Fan X; Zhu H; Han L; Li X; Xiao J; Kong X
    J Cell Mol Med; 2014 Mar; 18(3):542-53. PubMed ID: 24447518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.